Analyzing...
In continuation of our letter dated 14th October, 2024 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the Conference call held on 24th October, 2024, on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2024, is available on the Company’s website at https://www.piramalpharma.com/financial-reports Kindly take the above on record.
Thanking you,